[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fUo-qDDEUhfgGchNQ59B2LSf8aWz1CzmZg8_o26bx-d8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":30,"phaseBuckets":41,"rows":48},"Maimonides Medical Center",[4],53,false,5,3,3397,2,28,[14,16,18,20,22,24,26,28],{"name":15,"count":9},"Postoperative Pain",{"name":17,"count":9},"Prostate Cancer",{"name":19,"count":11},"Respiratory Distress Syndrome",{"name":21,"count":11},"Prader-Willi Syndrome",{"name":23,"count":11},"Aggression",{"name":25,"count":11},"Frail Elderly",{"name":27,"count":11},"Obesity",{"name":29,"count":11},"Polycystic Ovary Syndrome",[31,36],{"nctId":32,"briefTitle":33,"date":34,"intervention":35},"NCT04807894","Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo","2026-08-31","Vaginal Cream with Applicator",{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT07492160","Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms","2028-02","Cabergoline",[42,43,44,45,46,47],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[49,76,99,148,182,218,248,273,298,340,367,385,409,433,451,476,494,512,540,566,584,609,627,652,679,703,727],{"intervention":35,"totalTrials":50,"cells":51},1,{"EARLY_PHASE1":52,"PHASE1":55,"PHASE2":57,"PHASE3":59,"PHASE4":61,"NA":74},{"trials":53,"activeCount":54},[],0,{"trials":56,"activeCount":54},[],{"trials":58,"activeCount":54},[],{"trials":60,"activeCount":54},[],{"trials":62,"activeCount":50,"soonestReadout":34},[63],{"nctId":32,"briefTitle":33,"status":64,"phases":65,"primaryCompletion":34,"completion":66,"start":67,"enrollment":68,"conditions":69,"interventions":73},"RECRUITING",[46],"2026-12-31","2020-11-01",100,[70,71,72],"Recurrent Urinary Tract Infection","Vaginal Atrophy","Postmenopausal Disorder",[35],{"trials":75,"activeCount":54},[],{"intervention":40,"totalTrials":50,"cells":77},{"EARLY_PHASE1":78,"PHASE1":80,"PHASE2":82,"PHASE3":93,"PHASE4":95,"NA":97},{"trials":79,"activeCount":54},[],{"trials":81,"activeCount":54},[],{"trials":83,"activeCount":50,"soonestReadout":39},[84],{"nctId":37,"briefTitle":38,"status":64,"phases":85,"primaryCompletion":39,"completion":86,"start":87,"enrollment":88,"conditions":89,"interventions":92},[44],"2028-04","2026-03-16",348,[90,91],"Pregnancy","Abortion",[40],{"trials":94,"activeCount":54},[],{"trials":96,"activeCount":54},[],{"trials":98,"activeCount":54},[],{"intervention":100,"totalTrials":9,"cells":101},"Exparel",{"EARLY_PHASE1":102,"PHASE1":104,"PHASE2":106,"PHASE3":108,"PHASE4":110,"NA":146},{"trials":103,"activeCount":54},[],{"trials":105,"activeCount":54},[],{"trials":107,"activeCount":54},[],{"trials":109,"activeCount":54},[],{"trials":111,"activeCount":54},[112,124,135],{"nctId":113,"briefTitle":114,"status":115,"phases":116,"primaryCompletion":117,"completion":118,"start":119,"enrollment":120,"conditions":121,"interventions":123},"NCT03638011","A Comparison of the Post-C\u002FS Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine","TERMINATED",[46],"2020-03-31","2020-06-30","2018-09-25",71,[122],"Caesarean Section",[100],{"nctId":125,"briefTitle":126,"status":127,"phases":128,"primaryCompletion":129,"completion":129,"start":130,"enrollment":131,"conditions":132,"interventions":134},"NCT02011464","Evaluation Exparel Delivered in Knee Replacement","COMPLETED",[46],"2015-09","2013-12",20,[133],"Arthritis",[100],{"nctId":136,"briefTitle":137,"status":127,"phases":138,"primaryCompletion":139,"completion":139,"start":140,"enrollment":141,"conditions":142,"interventions":144},"NCT03769714","EXPAREL for Minimally Invasive Supracervical Hysterectomies",[46],"2019-06-30","2018-10-01",60,[143],"Pain",[145,100],"Saline Solution for",{"trials":147,"activeCount":54},[],{"intervention":149,"totalTrials":11,"cells":150},"Vitamin D3",{"EARLY_PHASE1":151,"PHASE1":153,"PHASE2":155,"PHASE3":157,"PHASE4":159,"NA":180},{"trials":152,"activeCount":54},[],{"trials":154,"activeCount":54},[],{"trials":156,"activeCount":54},[],{"trials":158,"activeCount":54},[],{"trials":160,"activeCount":54},[161,172],{"nctId":162,"briefTitle":163,"status":127,"phases":164,"primaryCompletion":165,"completion":166,"start":167,"enrollment":168,"conditions":169,"interventions":171},"NCT03644212","Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS",[46],"2013-09","2013-10","2012-07",79,[29,170],"Vitamin D Deficiency",[149],{"nctId":173,"briefTitle":174,"status":127,"phases":175,"primaryCompletion":176,"completion":176,"start":166,"enrollment":177,"conditions":178,"interventions":179},"NCT02460380","The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome",[46],"2015-03",93,[29,170],[149],{"trials":181,"activeCount":54},[],{"intervention":183,"totalTrials":11,"cells":184},"Dexmedetomidine",{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":191,"PHASE4":203,"NA":216},{"trials":186,"activeCount":54},[],{"trials":188,"activeCount":54},[],{"trials":190,"activeCount":54},[],{"trials":192,"activeCount":54},[193],{"nctId":194,"briefTitle":195,"status":196,"phases":197,"primaryCompletion":198,"completion":198,"start":199,"enrollment":54,"conditions":200,"interventions":202},"NCT05304598","Using Dexmedetomidine Prior to Intubation in Neonates","WITHDRAWN",[45],"2024-08-20","2022-03-14",[201],"Effect Neonatal",[183],{"trials":204,"activeCount":54},[205],{"nctId":206,"briefTitle":207,"status":127,"phases":208,"primaryCompletion":209,"completion":167,"start":210,"enrollment":211,"conditions":212,"interventions":214},"NCT02469961","Dexmedetomidine vs Propofol TIVA (Total Intravenous Anesthesia) and Interscalene Block",[46],"2011-08","2010-10",50,[213],"Shoulder Pain",[183,215],"Propofol",{"trials":217,"activeCount":54},[],{"intervention":145,"totalTrials":11,"cells":219},{"EARLY_PHASE1":220,"PHASE1":222,"PHASE2":224,"PHASE3":226,"PHASE4":240,"NA":246},{"trials":221,"activeCount":54},[],{"trials":223,"activeCount":54},[],{"trials":225,"activeCount":54},[],{"trials":227,"activeCount":54},[228],{"nctId":229,"briefTitle":230,"status":196,"phases":231,"primaryCompletion":118,"completion":232,"start":233,"enrollment":54,"conditions":234,"interventions":238},"NCT03544073","GnRH Agonist at Embryo Transfer: IVF Outcomes",[45],"2021-06-30","2019-04-15",[235,236,237],"Infertility","Infertility, Female","Infertility, Male",[145,239],"Leuprolide Acetate",{"trials":241,"activeCount":54},[242],{"nctId":136,"briefTitle":137,"status":127,"phases":243,"primaryCompletion":139,"completion":139,"start":140,"enrollment":141,"conditions":244,"interventions":245},[46],[143],[145,100],{"trials":247,"activeCount":54},[],{"intervention":249,"totalTrials":50,"cells":250},"0.5% ropivacaine",{"EARLY_PHASE1":251,"PHASE1":253,"PHASE2":255,"PHASE3":257,"PHASE4":259,"NA":271},{"trials":252,"activeCount":54},[],{"trials":254,"activeCount":54},[],{"trials":256,"activeCount":54},[],{"trials":258,"activeCount":54},[],{"trials":260,"activeCount":54},[261],{"nctId":262,"briefTitle":263,"status":127,"phases":264,"primaryCompletion":265,"completion":265,"start":266,"enrollment":267,"conditions":268,"interventions":270},"NCT02571439","Comparative Study of Two Different Techniques to Perform TAP-blocks",[46],"2015-08","2014-10",41,[269],"POSTOPERATIVE PAIN",[249],{"trials":272,"activeCount":54},[],{"intervention":274,"totalTrials":50,"cells":275},"Exparel infiltration",{"EARLY_PHASE1":276,"PHASE1":278,"PHASE2":280,"PHASE3":282,"PHASE4":284,"NA":296},{"trials":277,"activeCount":54},[],{"trials":279,"activeCount":54},[],{"trials":281,"activeCount":54},[],{"trials":283,"activeCount":54},[],{"trials":285,"activeCount":54},[286],{"nctId":287,"briefTitle":288,"status":115,"phases":289,"primaryCompletion":290,"completion":290,"start":291,"enrollment":292,"conditions":293,"interventions":295},"NCT02008370","Exparel in Minimally Invasive Cardiac Surgery",[46],"2016-06","2013-11",9,[294],"Cardiac Disease",[274],{"trials":297,"activeCount":54},[],{"intervention":299,"totalTrials":50,"cells":300},"Guanfacine Extended Release",{"EARLY_PHASE1":301,"PHASE1":303,"PHASE2":305,"PHASE3":307,"PHASE4":309,"NA":338},{"trials":302,"activeCount":54},[],{"trials":304,"activeCount":54},[],{"trials":306,"activeCount":54},[],{"trials":308,"activeCount":54},[],{"trials":310,"activeCount":54},[311],{"nctId":312,"briefTitle":313,"status":127,"phases":314,"primaryCompletion":315,"completion":315,"start":316,"enrollment":317,"conditions":318,"interventions":337},"NCT05657860","Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome",[46],"2023-12-16","2020-12-17",15,[21,23,319,320,321,322,323,324,325,326,327,328,329,27,330,331,332,333,334,335,336],"Self-Injurious Behavior","Pathologic Processes","Behavioral Symptoms","Intellectual Disability","Neurobehavioral Manifestations","Neurologic Manifestations","Nervous System Diseases","Abnormalities, Multiple","Congenital Abnormalities","Chromosome Disorders","Genetic Diseases, Inborn","Overnutrition","Nutrition Disorders","Antihypertensive Agents","Neurotransmitter Agents","Molecular Mechanisms of Pharmacological Action","Physiological Effects of Drugs","Skin-Picking",[299],{"trials":339,"activeCount":54},[],{"intervention":341,"totalTrials":50,"cells":342},"Bupivacaine liposome",{"EARLY_PHASE1":343,"PHASE1":345,"PHASE2":347,"PHASE3":349,"PHASE4":351,"NA":365},{"trials":344,"activeCount":54},[],{"trials":346,"activeCount":54},[],{"trials":348,"activeCount":54},[],{"trials":350,"activeCount":54},[],{"trials":352,"activeCount":54},[353],{"nctId":354,"briefTitle":355,"status":127,"phases":356,"primaryCompletion":357,"completion":357,"start":358,"enrollment":211,"conditions":359,"interventions":363},"NCT03502018","Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty",[46],"2023-08-31","2018-03-01",[360,361,362],"Intracapsular Fracture of Femur","Femoral Neck Fractures","Hip Hemiarthroplasty",[341,364],"Saline",{"trials":366,"activeCount":54},[],{"intervention":364,"totalTrials":50,"cells":368},{"EARLY_PHASE1":369,"PHASE1":371,"PHASE2":373,"PHASE3":375,"PHASE4":377,"NA":383},{"trials":370,"activeCount":54},[],{"trials":372,"activeCount":54},[],{"trials":374,"activeCount":54},[],{"trials":376,"activeCount":54},[],{"trials":378,"activeCount":54},[379],{"nctId":354,"briefTitle":355,"status":127,"phases":380,"primaryCompletion":357,"completion":357,"start":358,"enrollment":211,"conditions":381,"interventions":382},[46],[360,361,362],[341,364],{"trials":384,"activeCount":54},[],{"intervention":386,"totalTrials":50,"cells":387},"On-Q Pain Pump",{"EARLY_PHASE1":388,"PHASE1":390,"PHASE2":392,"PHASE3":394,"PHASE4":396,"NA":407},{"trials":389,"activeCount":54},[],{"trials":391,"activeCount":54},[],{"trials":393,"activeCount":54},[],{"trials":395,"activeCount":54},[],{"trials":397,"activeCount":54},[398],{"nctId":399,"briefTitle":400,"status":127,"phases":401,"primaryCompletion":402,"completion":402,"start":403,"enrollment":404,"conditions":405,"interventions":406},"NCT00533845","Intraperitoneal Bupivicaine Infusion Using the On-Q Pain Pump After Laparoscopic Surgery",[46],"2010-01","2007-09",30,[15],[386],{"trials":408,"activeCount":54},[],{"intervention":410,"totalTrials":50,"cells":411},"Hyperbaric Oxygen Therapy",{"EARLY_PHASE1":412,"PHASE1":414,"PHASE2":416,"PHASE3":418,"PHASE4":420,"NA":431},{"trials":413,"activeCount":54},[],{"trials":415,"activeCount":54},[],{"trials":417,"activeCount":54},[],{"trials":419,"activeCount":54},[],{"trials":421,"activeCount":54},[422],{"nctId":423,"briefTitle":424,"status":115,"phases":425,"primaryCompletion":426,"completion":426,"start":427,"enrollment":50,"conditions":428,"interventions":430},"NCT04409886","Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients",[46],"2021-01-31","2020-06-01",[429],"COVID, Coronavirus",[410],{"trials":432,"activeCount":54},[],{"intervention":215,"totalTrials":50,"cells":434},{"EARLY_PHASE1":435,"PHASE1":437,"PHASE2":439,"PHASE3":441,"PHASE4":443,"NA":449},{"trials":436,"activeCount":54},[],{"trials":438,"activeCount":54},[],{"trials":440,"activeCount":54},[],{"trials":442,"activeCount":54},[],{"trials":444,"activeCount":54},[445],{"nctId":206,"briefTitle":207,"status":127,"phases":446,"primaryCompletion":209,"completion":167,"start":210,"enrollment":211,"conditions":447,"interventions":448},[46],[213],[183,215],{"trials":450,"activeCount":54},[],{"intervention":452,"totalTrials":50,"cells":453},"Ketorolac",{"EARLY_PHASE1":454,"PHASE1":456,"PHASE2":458,"PHASE3":460,"PHASE4":462,"NA":474},{"trials":455,"activeCount":54},[],{"trials":457,"activeCount":54},[],{"trials":459,"activeCount":54},[],{"trials":461,"activeCount":54},[],{"trials":463,"activeCount":54},[464],{"nctId":465,"briefTitle":466,"status":127,"phases":467,"primaryCompletion":468,"completion":468,"start":469,"enrollment":470,"conditions":471,"interventions":472},"NCT00638508","ON-Q Pump Infusion of Ketorolac and Ropivacaine at the Wound Site for Postoperative Pain Management",[46],"2008-08","2007-06",67,[15],[452,473],"Ketorolac and Ropivacaine",{"trials":475,"activeCount":54},[],{"intervention":473,"totalTrials":50,"cells":477},{"EARLY_PHASE1":478,"PHASE1":480,"PHASE2":482,"PHASE3":484,"PHASE4":486,"NA":492},{"trials":479,"activeCount":54},[],{"trials":481,"activeCount":54},[],{"trials":483,"activeCount":54},[],{"trials":485,"activeCount":54},[],{"trials":487,"activeCount":54},[488],{"nctId":465,"briefTitle":466,"status":127,"phases":489,"primaryCompletion":468,"completion":468,"start":469,"enrollment":470,"conditions":490,"interventions":491},[46],[15],[452,473],{"trials":493,"activeCount":54},[],{"intervention":239,"totalTrials":50,"cells":495},{"EARLY_PHASE1":496,"PHASE1":498,"PHASE2":500,"PHASE3":502,"PHASE4":508,"NA":510},{"trials":497,"activeCount":54},[],{"trials":499,"activeCount":54},[],{"trials":501,"activeCount":54},[],{"trials":503,"activeCount":54},[504],{"nctId":229,"briefTitle":230,"status":196,"phases":505,"primaryCompletion":118,"completion":232,"start":233,"enrollment":54,"conditions":506,"interventions":507},[45],[235,236,237],[145,239],{"trials":509,"activeCount":54},[],{"trials":511,"activeCount":54},[],{"intervention":513,"totalTrials":50,"cells":514},"Minocycline",{"EARLY_PHASE1":515,"PHASE1":517,"PHASE2":519,"PHASE3":521,"PHASE4":536,"NA":538},{"trials":516,"activeCount":54},[],{"trials":518,"activeCount":54},[],{"trials":520,"activeCount":54},[],{"trials":522,"activeCount":54},[523],{"nctId":524,"briefTitle":525,"status":115,"phases":526,"primaryCompletion":527,"completion":527,"start":528,"enrollment":11,"conditions":529,"interventions":535},"NCT06107725","Maimonides Minocycline in Stroke Study",[44,45],"2024-05-09","2023-11-01",[530,531,532,533,534],"Stroke, Acute","Ischemic Stroke","Hemorrhagic Stroke","Mortality","Morbidity",[513],{"trials":537,"activeCount":54},[],{"trials":539,"activeCount":54},[],{"intervention":541,"totalTrials":50,"cells":542},"Colchicine",{"EARLY_PHASE1":543,"PHASE1":545,"PHASE2":547,"PHASE3":560,"PHASE4":562,"NA":564},{"trials":544,"activeCount":54},[],{"trials":546,"activeCount":54},[],{"trials":548,"activeCount":54},[549],{"nctId":550,"briefTitle":551,"status":115,"phases":552,"primaryCompletion":553,"completion":553,"start":554,"enrollment":555,"conditions":556,"interventions":558},"NCT04363437","COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19",[44],"2020-07-31","2020-04-26",21,[557],"Coronavirus Infection",[541,559],"Usual Care",{"trials":561,"activeCount":54},[],{"trials":563,"activeCount":54},[],{"trials":565,"activeCount":54},[],{"intervention":559,"totalTrials":50,"cells":567},{"EARLY_PHASE1":568,"PHASE1":570,"PHASE2":572,"PHASE3":578,"PHASE4":580,"NA":582},{"trials":569,"activeCount":54},[],{"trials":571,"activeCount":54},[],{"trials":573,"activeCount":54},[574],{"nctId":550,"briefTitle":551,"status":115,"phases":575,"primaryCompletion":553,"completion":553,"start":554,"enrollment":555,"conditions":576,"interventions":577},[44],[557],[541,559],{"trials":579,"activeCount":54},[],{"trials":581,"activeCount":54},[],{"trials":583,"activeCount":54},[],{"intervention":585,"totalTrials":50,"cells":586},"Milrinone",{"EARLY_PHASE1":587,"PHASE1":589,"PHASE2":591,"PHASE3":603,"PHASE4":605,"NA":607},{"trials":588,"activeCount":54},[],{"trials":590,"activeCount":54},[],{"trials":592,"activeCount":54},[593],{"nctId":594,"briefTitle":595,"status":196,"phases":596,"primaryCompletion":597,"completion":597,"start":598,"enrollment":54,"conditions":599,"interventions":601},"NCT02644057","Dobutamaine Versus Milrinone in Cardiorenal Syndrome",[44],"2016-09","2016-03",[600],"Cardiorenal Syndrome",[585,602],"Dobutamine",{"trials":604,"activeCount":54},[],{"trials":606,"activeCount":54},[],{"trials":608,"activeCount":54},[],{"intervention":602,"totalTrials":50,"cells":610},{"EARLY_PHASE1":611,"PHASE1":613,"PHASE2":615,"PHASE3":621,"PHASE4":623,"NA":625},{"trials":612,"activeCount":54},[],{"trials":614,"activeCount":54},[],{"trials":616,"activeCount":54},[617],{"nctId":594,"briefTitle":595,"status":196,"phases":618,"primaryCompletion":597,"completion":597,"start":598,"enrollment":54,"conditions":619,"interventions":620},[44],[600],[585,602],{"trials":622,"activeCount":54},[],{"trials":624,"activeCount":54},[],{"trials":626,"activeCount":54},[],{"intervention":628,"totalTrials":50,"cells":629},"Lymphoseek and VBD Sln dissection",{"EARLY_PHASE1":630,"PHASE1":632,"PHASE2":634,"PHASE3":646,"PHASE4":648,"NA":650},{"trials":631,"activeCount":54},[],{"trials":633,"activeCount":54},[],{"trials":635,"activeCount":54},[636],{"nctId":637,"briefTitle":638,"status":127,"phases":639,"primaryCompletion":290,"completion":290,"start":640,"enrollment":641,"conditions":642,"interventions":645},"NCT01902953","Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)",[44],"2013-03",16,[643,644],"Colon Cancer","Rectal Cancer",[628],{"trials":647,"activeCount":54},[],{"trials":649,"activeCount":54},[],{"trials":651,"activeCount":54},[],{"intervention":653,"totalTrials":50,"cells":654},"Indocyanine Green",{"EARLY_PHASE1":655,"PHASE1":657,"PHASE2":659,"PHASE3":661,"PHASE4":663,"NA":665},{"trials":656,"activeCount":54},[],{"trials":658,"activeCount":54},[],{"trials":660,"activeCount":54},[],{"trials":662,"activeCount":54},[],{"trials":664,"activeCount":54},[],{"trials":666,"activeCount":54},[667],{"nctId":668,"briefTitle":669,"status":127,"phases":670,"primaryCompletion":671,"completion":671,"start":672,"enrollment":68,"conditions":673,"interventions":678},"NCT01424215","The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy",[47],"2014-08","2011-01",[674,675,676,677],"Cholelithiasis","Cholecystitis","Pancreatitis Biliary","Colic of Gallbladder Without Mention of Cholecystitis",[653],{"intervention":680,"totalTrials":50,"cells":681},"Growth Hormone",{"EARLY_PHASE1":682,"PHASE1":684,"PHASE2":686,"PHASE3":688,"PHASE4":690,"NA":692},{"trials":683,"activeCount":54},[],{"trials":685,"activeCount":54},[],{"trials":687,"activeCount":54},[],{"trials":689,"activeCount":54},[],{"trials":691,"activeCount":54},[],{"trials":693,"activeCount":54},[694],{"nctId":695,"briefTitle":696,"status":196,"phases":697,"primaryCompletion":698,"completion":698,"start":699,"enrollment":54,"conditions":700,"interventions":702},"NCT01970800","The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature",[47],"2014-12","2013-01",[701],"Short Stature",[680],{"intervention":704,"totalTrials":50,"cells":705},"Prednisone Priming",{"EARLY_PHASE1":706,"PHASE1":708,"PHASE2":710,"PHASE3":712,"PHASE4":714,"NA":716},{"trials":707,"activeCount":54},[],{"trials":709,"activeCount":54},[],{"trials":711,"activeCount":54},[],{"trials":713,"activeCount":54},[],{"trials":715,"activeCount":54},[],{"trials":717,"activeCount":54},[718],{"nctId":719,"briefTitle":720,"status":196,"phases":721,"primaryCompletion":722,"completion":722,"start":723,"enrollment":54,"conditions":724,"interventions":726},"NCT00715715","Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients",[47],"2011-02","2008-04",[725],"Chronic Hepatitis B",[704],{"intervention":728,"totalTrials":50,"cells":729},"Ropivacaine",{"EARLY_PHASE1":730,"PHASE1":732,"PHASE2":734,"PHASE3":736,"PHASE4":738,"NA":740},{"trials":731,"activeCount":54},[],{"trials":733,"activeCount":54},[],{"trials":735,"activeCount":54},[],{"trials":737,"activeCount":54},[],{"trials":739,"activeCount":54},[],{"trials":741,"activeCount":54},[742],{"nctId":743,"briefTitle":744,"status":115,"phases":745,"primaryCompletion":746,"completion":746,"start":747,"enrollment":748,"conditions":749,"interventions":750},"NCT02893423","Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia",[47],"2016-09-30","2013-01-01",51,[15],[728]]